ClinicalTrials.Veeva

Menu
S

Stanford Health Care | Stanford Neuroscience Health Center (SNHC)

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BHV-7000
Platinum
Voriconazole
Isavuconazonium sulfate
Posaconazole
JNJ-81201887
thiazide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials
Locations recently updated

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy (RISE 2)

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Enrolling
Focal Epilepsy
Drug: BHV-7000
Drug: Placebo
Locations recently updated

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Active, not recruiting
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure

A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose
Biological: Genetic: AAV5-hRKp.RPGR Low Dose

A clinical trial of AAV5-RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR

Trial sponsors

Stanford University logo
Janssen (J&J Innovative Medicine) logo
Astellas logo
Biohaven logo
C
Genentech logo
I
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems